Paul Mahon
2017
In 2017, Paul Mahon earned a total compensation of $12.9M as Executive Vice President and General Counsel at United Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,399,858 |
|---|---|
| Non-Equity Incentive Plan | $656,256 |
| Option Awards | $9,977,780 |
| Salary | $815,950 |
| Other | $21,600 |
| Total | $12,871,444 |
Mahon received $10M in option awards, accounting for 78% of the total pay in 2017.
Mahon also received $1.4M of change in pension value and nonqualified deferred compensation earnings, $656.3K in non-equity incentive plan, $816K in salary and $21.6K in other compensation.
Rankings
In 2017, Paul Mahon's compensation ranked 390th out of 14,666 executives tracked by ExecPay. In other words, Mahon earned more than 97.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 390 out of 14,666 | 97th |
Division Manufacturing | 125 out of 5,768 | 98th |
Major group Chemicals And Allied Products | 31 out of 2,074 | 99th |
Industry group Drugs | 21 out of 1,730 | 99th |
Industry Pharmaceutical Preparations | 18 out of 1,329 | 99th |
Source: SEC filing on April 27, 2018.
Mahon's colleagues
We found three more compensation records of executives who worked with Paul Mahon at United Therapeutics in 2017.